Physician profile
Anil M Singhal
NPI 1790958049
$1,083.53
in general payments reported to CMS, 2019-2025
14 companies · $405 in 2025
The $405 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10.79 · 2023: $332 · 2024: $336 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $368.82 | 2023-2025 | Collagenase Santyl, Grafix, Grafix Pl |
| Organogenesis INC. | $191.16 | 2023 | Puraply |
| Tactile Systems Technology INC | $152.35 | 2025 | Nimbl, Flexitouch Plus |
| Solventum Corporation | $75.32 | 2024-2025 | Snap, Activ.A.C. |
| Integra Lifesciences Corporation | $54.01 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biotissue Holdings INC. | $45.20 | 2024 | |
| Molnlycke Health Care US, LLC | $35.05 | 2023-2024 | Mepilex Border Sacrum, Exufiber Ag+, Mepilex Border Flex |
| Mimedx Group, INC. | $32.19 | 2025 | |
| Aroa Biosurgery Incorporated | $29.06 | 2024 | |
| Coloplast Corp | $28.67 | 2023 | Sensura Mio |
| Musculoskeletal Transplant Foundation INC. | $20.83 | 2023 | |
| Kerecis Limited | $20.79 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ovik Health, LLC | $19.29 | 2024 | Coflex Tlc |
| Penumbra, INC. | $10.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Singhal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.